BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10028305)

  • 1. Clinical characteristics and blood product usage in AIDS-associated lymphoma in haemophiliacs: a case-control study.
    Ragni MV; Belle SH; Bass D; Duerstein S; Kingsley LA
    Haemophilia; 1998 Nov; 4(6):826-35. PubMed ID: 10028305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in hemophiliacs. Hemophilia Malignancy Study Group.
    Ragni MV; Belle SH; Jaffe R; Locker J; Duerstein SL; Bass DC; Addiego JE; Aledort LM; Barron LE; Brettler DB; Buchanan GR; Gill JC; Ewenstein BM; Green D; Hilgartner MW; Hoots WK; Kisker CT; Lovrien EW; Rutherford CJ; Sanders NL; Smith KJ; Stabler SP; Swindells S; White GC; Kingsley LA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):78-86. PubMed ID: 8797689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
    Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
    J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
    Diamond C; Taylor TH; Im T; Anton-Culver H
    Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-transmitted disease.
    Lee CA
    Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.
    Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H
    Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study.
    Spagnuolo V; Travi G; Galli L; Cossarini F; Guffanti M; Gianotti N; Salpietro S; Lazzarin A; Castagna A
    Cancer; 2013 Aug; 119(15):2710-9. PubMed ID: 23625649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
    Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to AIDS in French haemophiliacs: association with HLA-B35.
    Sahmoud T; Laurian Y; Gazengel C; Sultan Y; Gautreau C; Costagliola D
    AIDS; 1993 Apr; 7(4):497-500. PubMed ID: 8507416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-associated lymphomas and other cancers in individuals with haemophilia.
    Ragni MV
    Haemophilia; 1996 Oct; 2(4):192-5. PubMed ID: 27214355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
    Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
    Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of microbial translocation and risk of AIDS-related lymphoma.
    Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
    AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
    Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy.
    Dal Maso L; Rezza G; Zambon P; Tagliabue G; Crocetti E; Vercelli M; Zanetti R; Falcini F; Tonini G; Mangone L; De Lisi V; Ferretti S; Tumino R; Stanta G; Vitarelli S; Serraino D; Franceschi S;
    Int J Cancer; 2001 Aug; 93(3):430-5. PubMed ID: 11433410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for pediatric human immunodeficiency virus-related malignancy.
    Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
    JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.